Back to the site

Blog

We answer the questions buyers and growers ask about GACP, EU GMP and supplier qualification, one at a time.

Perspectives fromour CEO.

Riccardo Longato, Chief Executive, on the regulatory and market questions in the medical cannabis supply chain.

Photo: Brian Shamblen, Flickr, CC BY 2.0What does the Bedrocan bankruptcy mean for medical cannabis supply?Bedrocan went bankrupt on 7 October and Dutch exports stop at the end of 2026: what that means for Italy and what importers can check now.Read the article
Why do clients ask us whether we do everything?A pharmaceutical distributor we met in Berlin asked us for audits, then for software, then for a new brand, and this story shows how we work.
How does medical cannabis reach patients in Italy?Italian patients receive medical cannabis as pharmacy preparations, and Ministry data show that four kilograms in five reach pharmacies through importers.
Photo: Ryan Bushby (HighInBC), Wikimedia Commons, CC BY 2.5What happens to terpenes when cannabis is dried?Drying moves the terpene profile in a direction the literature reproduces, and the number you read depends on the metric the laboratory used.
Photo: Brian Shamblen, Wikimedia Commons, CC BY 2.0Who verifies GACP compliance for medical cannabis?The EMA guideline on GACP gives the check to the buyer, through regular audits of the grower’s sites, and its text describes no GACP certificate.
What does draft Annex 22 allow an AI assistant to do in GMP software?Draft Annex 22 keeps generative AI out of critical GMP applications, so what an assistant may do depends on where its output ends up.
What is the future of EU-GMP in medical cannabis?The legal base is being rewritten, certificates carry less weight, and the duty to verify stays with the buyer: my reading before the PTMC panel in Lisbon.
Photo: Oulu county archive, Wikimedia Commons, CC BY 4.0First-party or second-party audit: which one do you need?One looks inward at your own quality system, the other looks outward at your suppliers. EU GMP expects both, and neither can stand in for the other.
Where does GMP start for medical cannabis?Four EU texts pass the question to each other: how GACP, Annex 7, Part II and ICH Q9 build a defensible GMP boundary for cannabis.
Can a GMP supplier audit be done remotely?What EU GMP allows for remote, on-site and hybrid supplier audits, and how to choose with the regulatory texts in hand.

Research

Here we publish our longer technical work in full, including reviews in which we read the evidence against the European texts.

Where the science of drying medicinal cannabis stands, and what it means for supplier qualification

Read the review

Would you rather talk it through first?

Talk to us

or Request a quotation